AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $6.89
- 52-wk high
- $7.72
- High
- $7.02
- 52-wk low
- $2.99
- Low
- $6.72
- Prev close
- $7.10
- Mkt cap
- $2.43B
- Volume
- 2.77M
- Fwd P/E
- 15.6x
- Beta
- 1.02
- P/S
- 28.4x
- P/B
- 56.4x
- Profit margin
- -184.0%
- Op margin
- +41.2%
- ROE
- -837.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
Earnings
Earnings came in $0.07 a share above what analysts expected.
Earnings per share
-$0.02 expected
What the street expects next
EPS expected
$0.05 to $0.14
Revenue expected
3 analysts
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.9M | $4.6M | $23.3M | $55.0M |
| Cost of what it sold | $1.4M | $1.9M | $2.9M | $2.8M |
| Gross profit | $1.6M | $2.7M | $20.4M | $52.2M |
| What it spent | ||||
| Research and development | $12.1M | $6.7M | $5.3M | $7.3M |
| Sales and admin | $24.0M | $17.6M | $21.0M | $22.2M |
| Total operating expenses | $36.0M | $24.3M | $26.4M | $29.5M |
| What was left | ||||
| Operating profit | -$34.5M | -$21.7M | -$6.0M | $22.6M |
| Interest on debt | $902.0K | $3.0M | $2.9M | $3.0M |
| Profit before tax | -$146.3M | -$23.5M | -$7.9M | $20.1M |
| Tax | $179.0M | $6.0K | — | — |
| Net profit | -$146.3M | -$23.5M | -$7.9M | $20.1M |
| EBITDA | -$144.6M | -$19.4M | -$3.9M | $23.0M |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Q3 2025 Precigen Inc Earnings Call Transcript
Leans bullishAug 31Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen
BullishAug 27Precigen CCO Phil Tennant sells $593,745 in stock
Leans bullishAug 25Precigen COO Rutul Shah sells $375,000 in shares
NeutralAug 25Precigen (NASDAQ: PGEN) CFO settles RSUs, withholds 3,577 shares for taxes
NeutralAug 25Precigen (PGEN) COO unloads 50K shares at $7.50 under plan
NeutralAug 25Precigen (PGEN) insider lines up another stock sale after four recent trades
NeutralAug 25Precigen (NASDAQ: PGEN) officer to sell 79,166 shares in 2026
NeutralAug 25
Macro
11 macro signals shaping PGEN right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results